TeraImmune

About:

TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.

Website: https://www.teraimmune.com/

Top Investors: Shinhan Venture Investment

Description:

TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis, and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.

Total Funding Amount:

$2.96M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2016-09-01

Contact Email:

hyun(AT)teraimmune.com

Founders:

Jay Park, Yong Chan Kim

Number of Employees:

11-50

Last Funding Date:

2022-12-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai